BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23571732)

  • 1. Ezetimibe and bile acid sequestrants: impact on lipoprotein metabolism and beyond.
    Couture P; Lamarche B
    Curr Opin Lipidol; 2013 Jun; 24(3):227-32. PubMed ID: 23571732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
    Hou R; Goldberg AC
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ezetimibe in the prevention of cardiovascular disease: absence of evidence.
    Mascitelli L; Pezzetta F; Goldstein MR
    Arch Med Res; 2010 Nov; 41(8):649-50. PubMed ID: 21199735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal sterol transporters and cholesterol absorption inhibition.
    Davis HR; Tershakovec AM; Tomassini JE; Musliner T
    Curr Opin Lipidol; 2011 Dec; 22(6):467-78. PubMed ID: 22101558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
    Gotto AM; Farmer JA
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin and ezetimibe combination therapy in cardiovascular disease.
    Dembowski E; Davidson MH
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):183-8. PubMed ID: 19262375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ezetimibe: cholesterol lowering and beyond.
    Bays HE; Neff D; Tomassini JE; Tershakovec AM
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):447-70. PubMed ID: 18402536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model of intestinal chylomicron over-production and ezetimibe treatment: impact on the retention of cholesterol in arterial vessels.
    Mangat R; Warnakula S; Wang Y; Russell JC; Uwiera R; Vine DF; Proctor SD
    Atheroscler Suppl; 2010 Jun; 11(1):17-24. PubMed ID: 20471328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic interaction between ezetimibe and rosuvastatin.
    Kosoglou T; Statkevich P; Yang B; Suresh R; Zhu Y; Boutros T; Maxwell SE; Tiessen R; Cutler DL
    Curr Med Res Opin; 2004 Aug; 20(8):1185-95. PubMed ID: 15324521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezetimibe (Schering-Plough).
    Meng CQ
    Curr Opin Investig Drugs; 2001 Mar; 2(3):389-92. PubMed ID: 11575710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The place of ezetimibe in clinical practice.
    Weston C
    Hosp Med; 2003 Aug; 64(8):473-8. PubMed ID: 12958759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of ezetimibe in the prevention of cardiovascular disease: where do we stand after ARBITER 6-HALTS.
    Howard WJ
    Nutr Metab Cardiovasc Dis; 2010 Jun; 20(5):295-300. PubMed ID: 20556890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety considerations with gastrointestinally active lipid-lowering drugs.
    Jacobson TA; Armani A; McKenney JM; Guyton JR
    Am J Cardiol; 2007 Mar; 99(6A):47C-55C. PubMed ID: 17368279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.
    Bruckert E; Giral P; Tellier P
    Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406
    [No Abstract]   [Full Text] [Related]  

  • 16. Human cholesterol metabolism and therapeutic molecules.
    Charlton-Menys V; Durrington PN
    Exp Physiol; 2008 Jan; 93(1):27-42. PubMed ID: 18165431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
    Daskalopoulou SS; Mikhailidis DP
    Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ezetimibe controversy: implications for clinical practice.
    Khanderia U; Regal RE; Rubenfire M; Boyden T
    Ther Adv Cardiovasc Dis; 2011 Aug; 5(4):199-208. PubMed ID: 21636623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acid sequestrants: more than simple resins.
    Out C; Groen AK; Brufau G
    Curr Opin Lipidol; 2012 Feb; 23(1):43-55. PubMed ID: 22186660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigative look: selective cholesterol absorption inhibitors--embarking on a new standard of care.
    Stein EA
    Am J Manag Care; 2002 Feb; 8(2 Suppl):S36-9; discussion S45-7. PubMed ID: 11855701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.